Ebola prevention becomes easier to supply

WHO reports that the seventeenth observance in Ghana took place on 3 September 2019.

At the gathering, WHO discussed African institutions evaluating safety and quality of traditional treatments.

The WHO account notes research on traditional remedies proposed for malaria, diabetes and other conditions; it does not establish efficacy.

The 2019 national commemoration put research, practitioners and public health in conversation.

The vaccine met WHO standards for quality, safety and efficacy for procurement by health agencies.

Clinical research and public health response informed the vaccine’s path to prequalification.

The 12 November decision facilitated access but did not mean Ebola risk was gone.

The released genetic information enabled laboratories in many countries to begin developing diagnostic tests.

The newly available sequence let international teams compare the virus with other coronaviruses.

Public sequence data supplied a basis for molecular assays; validation and distribution followed later.